It has been demonstrated that many abnormalities in AD pathology (e.g., increased tau phosphorylation, disturbances in energy metabolism, neuronal growth as well as synaptic plasticity) may result from impaired insulin signalling in the CNS. The gene discussed is INS; the disease is Alzheimer disease.